
MONTREAL — Canada has authorized US pharmaceutical giant Moderna to begin clinical trials for a vaccine against the Bundibugyo strain of Ebola, the Canadian health ministry announced Tuesday. The Phase 1 trial of the mRNA vaccine “will…
View original source — Philippine Daily Inquirer ↗
